Rolicyclidine CAS: 2201-39-0

CAS NO: 2201-39-0
Rolicyclidine
Chemical Name: Rolicyclidine
Molecular Formula: C16H23N
Formula Weight: 229.36
CAS No.: 2201-39-0
Description Review
Description

Rolicyclidine is a synthetic hallucinogenic drug that belongs to the dissociative class of psychoactive substances. It is also known by its chemical name, 1-(1-phenylcyclohexyl)piperidine-2-carboxylic acid ethyl ester, and has a molecular formula of C20H29NO2. The formula weight of Rolicyclidine is 315.45 g/mol, and its CAS number is 2201-39-0. The drug is not approved for any medical use and is classified as a Schedule I controlled substance in the United States.

Top Ten Keywords and Synonyms:

  1. Rolicyclidine
  2. CAS: 2201-39-0
  3. 1-(1-phenylcyclohexyl)piperidine-2-carboxylic acid ethyl ester
  4. PCP analogue
  5. Dissociative drug
  6. Recreational drug
  7. Designer drug
  8. NMDA receptor antagonist
  9. Hallucinogen
  10. Illicit drug

Health Benefits of Rolicyclidine

There are no documented health benefits of Rolicyclidine, as it is not approved for medical use. In fact, the use and possession of this drug is illegal in most countries. Rolicyclidine is considered a recreational drug, and its effects on the body are not well understood.

Potential Effects

Rolicyclidine has similar effects to phencyclidine (PCP), which is a known hallucinogenic drug. It acts as an NMDA receptor antagonist, which means that it blocks the action of the neurotransmitter glutamate in the brain. This leads to altered sensory perception, dissociation from reality, and altered mood. Rolicyclidine can also cause hallucinations, delusions, and feelings of derealization and depersonalization.

In addition to its hallucinogenic effects, Rolicyclidine can cause physical changes in the body. Users may experience increased heart rate, blood pressure, and body temperature. They may also experience muscle rigidity, tremors, and seizures.

Product Mechanism

Rolicyclidine acts as an NMDA receptor antagonist, which means that it blocks the action of the neurotransmitter glutamate in the brain. This leads to altered sensory perception, dissociation from reality, and altered mood. The exact mechanism of action of Rolicyclidine is not well understood, but it is believed to interact with NMDA receptors in a similar way to PCP.

Safety

Rolicyclidine is an illicit drug, and its safety has not been established. Using Rolicyclidine can be extremely dangerous, as it can cause unpredictable and potentially life-threatening effects. The physical effects of the drug on the body can be particularly harmful, and repeated use of Rolicyclidine can lead to long-term health problems.

Side Effects

The short-term side effects of Rolicyclidine can include altered sensory perception, confusion, hallucinations, delusions, and feelings of derealization and depersonalization. The drug can also cause physical changes in the body, including increased heart rate, blood pressure, and body temperature, as well as muscle rigidity and tremors. In some cases, Rolicyclidine can cause seizures or coma.

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code